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a b s t r a c t
Hydrogen/deuterium exchange measurements by mass spectrometry (HX-MS) can be used to report
localized conformationalmobilitywithin foldedproteins,where exchangepredominantly occurs through
low energy ﬂuctuations in structure, allowing transient solvent exposure. Changes in conformational
mobilitymay impact protein function, even in caseswhere structural changes are unobservable. Previous
studies of the MAP kinase, ERK2, revealed increases in HX upon activation occurred at the hinge between
conserved N- and C-terminal domains, which could be ascribed to enhanced backbone ﬂexibility. This
implied that kinase activation modulates interdomain closure, and was supported by evidence for two
modes of nucleotide binding that were consistent with closed vs open conformations in active vs inactive
formsofERK2, respectively. Thus, phosphorylationofERK2releases constraints to interdomainclosure, by
modulating hinge ﬂexibility. In this study, we examined ERK1, which shares 90% sequence identity with
ERK2. HX-MS measurements of ERK1 showed similarities with ERK2 in overall deuteration, consistent
with their similar tertiary structures. However, the patterns of HX that were altered upon activation of
ERK1 differed from those in ERK2. In particular, alterations in HX at the hinge region upon activation
of ERK2 did not occur in ERK1, suggesting that the two enzymes differ with respect to their regulation
of hinge mobility and interdomain closure. In agreement, HX-MS measurements of nucleotide binding
suggested revealed domain closure in both inactive and active forms of ERK1. We conclude that although
ERK1 and ERK2 are closely related with respect to primary sequence and tertiary structure, they utilize
ontrodistinct mechanisms for c
. Introduction
Extracellular signal-regulated protein kinases, ERK1 and ERK2,
remitogen-activated protein (MAP) kinaseswhich control diverse
ellular responses, including cell proliferation, differentiation,
ransformation, and survival. ERK activation is frequently dysreg-
lated in human cancers, due to oncogenic mutations in upstream
athway components, including Ras, Raf, and MAP kinase kinase
MKK), as well as receptor tyrosine kinases, EGFR, Her2/Neu,
nd Met [1,2], all which are attractive targets for drug inter-
ention. Although ERK1 and ERK2 are functionally redundant in
any cell types, each shows a distinct mouse knockout pheno-
ype, where deletion of ERK2 leads to embryonic lethality while
eletion of ERK1 yields viable animals with defects in thymo-
yte maturation and immunodeﬁciency [3,4]. Thus, at least some
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functions of ERK1 and ERK2 are non-redundant. On the other
hand, relatively little is known about how regulatory mecha-
nisms controlling ERK1 and ERK2 differ, which might impact the
development of different strategies for speciﬁcally targeting each
form.
Crystallographic studies of ERK1 and ERK2 show a conserved
tertiary structure shared with all protein kinases, consisting of an
N-terminal ATP binding and C-terminal substrate binding domains
surrounding the catalytic site [5–8]. Both ERK1 and ERK2 are
activated by dual phosphorylation at a conserved pThr-Glu-pTyr
sequence located within the activation lip region, which is cat-
alyzed by the upstream MAP kinase kinases, MKK1 and MKK2.
Structural remodeling events which accompany ERK activation
have been revealed by X-ray structures of inactive, unphospho-
rylated (0P) and active, diphosphorylated (2P) forms of ERK2
[6–8]. Diphosphorylation triggers new phosphate-side chain ion
Open access under CC BY-NC-ND license.pair interactions which lead to dramatic conformational changes
within the activation lip, reorganizing the substrate binding site to
enable recognition of the proline-directed phosphorylation motif
(pSer/pThr-Pro), and reorienting active site residues involved in
catalysis.
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Hydrogen-exchange mass spectrometry (HX-MS) studies have
hown that protein kinases are regulated not only through changes
n conformation, but also through changes in conformational
obility. In previous studies of ERK2, comparisons between the
ctive and inactive states of this kinase revealed increased HX
n the hinge region upon activation, consistent with enhanced
exibility and conformer interconversions,whichwere not observ-
ble byX-ray crystallography [9]. Electron paramagnetic resonance
EPR) analysis of backbone residues in ERK2 that were individually
oupled to a MTSL nitroxide spin label probe demonstrated that
hanges in side chain correlation rates occurred upon phosphory-
ation and activation [10]. Taken together, the results suggested a
odel in which the changes in HX could be explained by regulated
rotein motions, such as underlying backbone ﬂexibility. Further
easurements of steric protection from HX by the ATP analogue,
MP-PNP, suggested a function for this control of hinge ﬂexibility.
n one hand, HX within the N-terminal domain was comparable
etween 0P-ERK2 and 2P-ERK2, in regions containing the Gly loop,
he conserved Lys-Glu ion pair within 3 and C, the hinge region,
nd the catalytic base, all of which are known to form close inter-
ctions with nucleotide [11]. On the other hand, 2P-ERK2 showed
0-fold greater protection from HX than 0P-ERK2 within the con-
ervedDFGmotif, part of the C-terminal domainwhich formsmetal
oordination interactions with Mg+2–ATP. Thus, AMP–PNP binding
terically protected both N- and C-terminal domains of 2P-ERK2
rom solvent, but mainly protected only the N-terminal domain
f 0P-ERK2. Because the two kinase forms shared similar binding
fﬁnities for AMP-PNP, the results suggested that distinct modes of
ucleotide binding occur in solution. The protection patterns are
onsistent with a model in which 2P-ERK2 adopts a closed con-
ormation, whereas 0P-ERK2 is somehow constrained to interfere
ith interdomain closure. Thus, HX protection by Mg+2–AMP–PNP
inding provides a useful way to monitor domain closure, an event
eeded to form a competent catalytic site. These results, together
ith the observed changes in hinge ﬂexibility upon activation, led
s topropose that activationof ERK2 releases constraints todomain
losure by increasing backbone ﬂexibility at the hinge [11].
Given their sequence and structural conservation, differentMAP
inasesmight be expected to show similar regulatorymechanisms.
nagreement, p38MAPkinaseappears toundergoconformational
earrangements following phosphorylation which parallel those
een in ERK2. For example, structural comparisons between p38
AP kinase in its inactive, unphosphorylated form and the related
38 MAP kinase in its active, diphosphorylated form show large
onformational changes within the activation lip following phos-
horylation by MKK3/6 [12–14]. Thus, although the activation lip
onformation of 0P-p38MAP kinase differs from that of 0P-ERK2,
he lip conformation of 2P-p38 MAP kinase is similar to that of
P-ERK2, revealing that diverse activation lip conformers in MAP
inases converge towards a uniform structure in the active state,
hich allows catalytic rate enhancement. In contrast, HX-MS stud-
es show that p38MAPkinase differs signiﬁcantly fromERK2with
espect to the patterns of regional HX which change in response to
inase activation [15]. This suggests that the effect of kinase activa-
ion on conformational mobility diverges between related protein
inases, leading to the hypothesis that different MAP kinases may
ave distinct mechanisms for regulating enzyme activity through
heir control of internal protein motions.
In this study, we wished to understand whether differences
n patterns of regulated conformational mobility upon activa-
ion might also be observed between enzymes that are even
ore closely related. Here, we analyzed ERK1, which shares 90%
equence identity with ERK2. We found that ERK1 showed signif-
cant differences in how the HX behavior changes in response to
inase activation within conserved regions of the core structure.
otably, ERK1 did not display altered HX within hinge residues asss Spectrometry 302 (2011) 101–109
previously observed in ERK2. This suggests that ERK1 might lack
constraints to interdomain closure which are present in the inac-
tive form of ERK2. In order to test this hypothesis, we measured
changes inprotection fromHXuponAMP–PNPbinding inERK1, and
compared these to prior studies of ERK2 [11]. The results showed
signiﬁcant protection from HX within the C-terminal domain of
both 0P-ERK1 and 2P-ERK1, indicating that both inactive and active
forms appear capable of interdomain closure in solution. Thus, the
occurrence and functional effects of regulated protein motions dif-
fer in substantive ways between ERK1 and ERK2.
2. Materials and methods
2.1. Protein puriﬁcation
Active, diphosphorylated (2P) ERK1 was produced from plas-
mid pET-His-ERK1-R4F, containing wild-type human His6-ERK1
expressed in tandem with constitutively active mutant MKK1
(R4F: N3/S218E/S222D) [16]. Inactive, unphosphorylated (0P)
human His6-ERK1 was produced using plasmid NpT7-ERK1 [17].
Each kinase form was expressed in E. coli strain BL21(DE3)-pLysS,
and puriﬁed using Ni-NTA agarose (Qiagen) chromatography,
desalted by gel ﬁltration (PD10, GE Healthcare), and further puri-
ﬁed by MonoQ FPLC. Proteins were dialyzed overnight into 50mM
KPO4 (pH 7.4), 100mM KCl and 5mM dithiothreitol, and stored
in aliquots at −80 ◦C. The 0P-ERK1 protein was found to be
mono-phosphorylated to 0.13mol/mol, and was therefore dephos-
phorylated using  phosphatase (New England Biolabs, 100U/g,
3h, 30 ◦C) before Mono Q separation. The activation lip phospho-
rylation stoichiometries of the ﬁnal kinase preparations showed
0% phosphorylation in 0P-ERK1 at the regulatory Thr and Tyr
residues in the activation lip, and 95% diphosphorylation in 2P-
ERK1. Intact ESI-MS of 0P-ERK1 and 2P-ERK1 showed full length
masses expected of the recombinant ERK1 sequences, in unphos-
phorylated and diphosphorylated forms (Supplementary Fig. S1).
2.2. HX-MS measurements
Datawere collected on aQStar Pulsar QqTOFmass spectrometer
(ABI) interfacedwith anAgilent Cap1100HPLC (0.5mm i.d.×10 cm
column, packed with POROS R1 20 resin), and measurements of
weighted average mass were performed as described [18,19]. Pro-
teins (4g) were incubated in 90% D2O (Sigma) at 10 ◦C, allowing
in-exchange reactions to take place between 8 s and 4h. Reactions
were quenched with 90L 25mM succinic acid, 25mM citric acid
(pH 2.4), and cooled rapidly to 0 ◦C. Proteins were digested by
adding 10L pepsin (4g) and analyzed immediately by LC–MS.
Time-zero measurements were performed by quenching the reac-
tion before adding D2O.
Peptides inpepsindigests of ERK1were identiﬁedbyLC–MS/MS,
analyzing replicate digests on two instruments in order to maxi-
mize the probability that a peptide would be selected for MS/MS.
Aliquots (4g) of proteolyzed ERK1 were analyzed on the QStar
mass spectrometer, with m/z window 400–1600Da, duty cycle
15.5 s, and three MS/MS per cycle. Aliquots (60ng) of ERK1
were analyzed on an LTQ-Orbitrap mass spectrometer interfaced
with an Eksigent 2DLC HPLC (75m i.d.×150mm column, Zor-
bax C18 resin), with m/z window 300–2000Da, duty cycle 4–6 s
(10–14 cycles/min), and ﬁve MS/MS per cycle. MS/MS were con-
verted to .mgf ﬁles and searched against the human ERK1 sequence
using MASCOT (v. 1.9), with no enzyme speciﬁed. Mass tolerances
were 2.5Da (parent) and 1.2Da (fragment) for QStar datasets, and
1.2Da (parent) and 0.6Da (fragment) for LTQ-Orbitrap datasets.
Peptides with MOWSE score greater than 20 were validated by
manual analysis ofMS/MS spectra. LC–MS of ERK1was then carried
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ut in water on the QStar, and only peptides with validated MS/MS
hat were also observed in the LC–MS run were reported.
HX-MS measurements of protection by Mg+2–AMP–PNP were
arried out as above, with the following modiﬁcations. Prior to
he HX reaction, 8L (5g) of 0P-ERK1 or 2P-ERK1 was incu-
ated on ice for 10min with either 7L of 21mM MgCl2 +2.1mM
MP–PNP or 7L of 21mM MgCl2. At t=0, exchange was initi-
ted by adding 85L of a D2O/solutemixture to the kinase solution
o reach a ﬁnal buffer composition of 85% (v/v) D2O, 25mM KPO4
pH 7.4), 50mM KCl, and 0.25mM DTT, 10mM MgCl2, and ±1mM
MP–PNP. Samples were incubated between 8 s and 110min at
0 ◦C to allow in-exchange, then quenched by acidiﬁcation with
0L 25mMsodiumsuccinate, 25mMsodiumcitrate (pH2.4), and
ooled to 0 ◦C. Proteins were digested by addition of pepsin, and
eptides were analyzed on the QStar mass spectrometer. Time-
ero controls were performed by quenching the sample prior to
ddition of the D2O/solute mixture. To avoid systematic variations,
ime points and the order of sample analysis ±AMP–PNP were
andomized.
Weightedaveragemassmeasurementswere facilitatedbyusing
n-house HX-Analyzer software [15]. Samples were randomized
ig. 1. Pepsin cleavage map of human ERK1. Shown is the sequence of His6-ERK1, indic
ll peptides indicated were present in LC–MS/MS datasets of ERK1 in water, as well a
04–209) were observed only in 0P-ERK1 datasets, and the peptide indicated with horizon
n proteolysis in the activation lip. One peptide indicated by a solid bar (173–179) show
ndicated by dotted ﬁll showed decreased in-exchange following phosphorylation and acss Spectrometry 302 (2011) 101–109 103
to control for systematic variations, and replicate runs were per-
formed at 0 and 60 s in order to quantify the average standard
deviation of weighted average mass (0.05Da) and maximum stan-
dard deviation (0.13Da). Estimates of artifactual in-exchange and
back-exchange were obtained as described [18,19]. Back-exchange
was estimated in twoways. First, back-exchangewas calculated for
each peptide using an empirical formula which assumes 1% back-
exchange per minute after quenching [Eq. (4) in Ref. [18]]. Second,
back-exchange was estimated by desalting and then lyophilizing
peptides generated from pepsin digestion of 2P-ERK1, incubating
with 90% D2O for 90min at 90 ◦C to allow complete in-exchange,
and measuring peptide mass by LC–MS under HX experimental
conditions [18,20]. When counting the number of exchangeable
amides for a given peptide, we included the ﬁrst amide proton and
did not assume rapid back-exchange on the timescale of the exper-
iment. The two methods for estimating back-exchange were in
reasonable agreement,where themeasured values yielded an aver-
age of 28±7% back-exchange for 21 observable peptides, while the
empirical calculation yielded an average of 22±2% back-exchange
for the same peptides. Therefore we applied the second method
involving back-exchange calculations to all peptides.
ating residue numbers and secondary structure as reported by Kinoshita et al. [5].
s HX datasets in D2O. Peptides indicated by stippled bars (−8–29, 188–203, and
tal stripes (188–209) was observed only in 2P-ERK1 datasets, reﬂecting differences
ed increased in-exchange following phosphorylation and activation, and peptides
tivation (see time courses in Supplementary Fig. S2).
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After correcting weighted average masses for artifactual
n-exchange and back-exchange, deuteration time courses
ere ﬁtted by nonlinear least squares to the equation
=N−Ae−k1t −Be−k2t −Ce−k3t, where Y is the number of deuterons
xchanged at time t; A, B, and C are the numbers of backbone
mides exchanging at rates k1, k2, and k3, respectively; and N
s the maximal deuteration over the experimental time period
N=A+B+C). Subtracting N from the total number of exchangeable
ackbone amides yields NE, the number of amides that are non-
xchanging over the experimental time period. Nonlinear least
quares calculations and graphics of time courses were generated
sing Sigmaplot v9.0 (SPSS Inc.).
ig. 2. Hydrogen exchange patterns in ERK1. (A and B) Extent of deuteration into (A) 0P-ER
ach region. For reach region, the extent of deuteration was measured as the sum of A+B+
5–50% (blue), 50–75% (cyan) and >75% (white) of exchangeable amides. Overall, ERK1 a
hat could be attributed to variations in sequence or structure. (C and D) Changes in HX
hat showed increased (red) or decreased (green) HX following activation by phosphory
1ERK). Peptides found in only one form of ERK1 or ERK2 (black) precluded comparison be
oth increased and decreased HX rates upon activation. Of particular interest was the hin
nterdomain closure, but in ERK1 was unaltered by kinase activation (see Supplementaryss Spectrometry 302 (2011) 101–109
3. Results
3.1. Hydrogen exchange measurements
Hydrogen–deuterium in-exchangemeasurements of ERK1were
obtained by LC–MS as described Section 2. Fifty-ﬁve peptides
were identiﬁed after pepsin proteolysis, ranging in length between
6 and 36 residues (Table S1). These accounted for 98% cover-
age of the primary sequence (370 of 379 residues), and 94%
coverage of exchangeable amides (334 of 356 amides). The pep-
tides are annotated onto the primary sequence of His6-ERK1
in Fig. 1.
K1 and (B) 0P-ERK2 after 4h, normalized by the number of exchangeable amides in
C (Supplementary Table S2), and mapped as colors corresponding to 0–25% (black),
nd ERK2 showed similar patterns of regional hydrogen exchange, with differences
induced upon phosphorylation and activation of (C) ERK1 and (D) ERK2. Peptides
lation were colored against the X-ray structures of 1P-ERK1 (2ZOQ) and 0P-ERK2
tween inactive and active kinases. Yellow denotes a peptide in ERK2 which showed
ge region, which in ERK2 underwent enhanced HX surrounding the pivot point for
Fig. S3). Data on ERK2 were from Lee et al. [11].
A.Y. Ring et al. / International Journal of Mass Spectrometry 302 (2011) 101–109 105
Fig. 3. HX time courses for peptides in ERK1 altered upon kinase activation. (A–J) Peptides are labeled by residue numbers as in Table S1, followed by the corresponding
amino acid sequence. HX data on 0P-ERK1 are indicated by closed circles (), and data on 2P-ERK1 are indicated by open circles (©). (I and J) Peptides 120–126 and 125–141
include the hinge region which in ERK1 showed no change upon activation, although HX within the sequence METDL was increased upon activation, in ERK2 [9,11].
1 of Ma
i
d
e
m
d
c
w
b
F
o
a06 A.Y. Ring et al. / International Journal
Information about the degree of HX occurring within local-
zed regions of 0P-ERK1 was assessed by measuring the extent of
euteration into different peptides over the 4h timescale of the
xperiment, and mapping these against an X-ray structure deter-
ined for ERK1 [5] (Fig. 2A, Table S2). Slow exchange, leading to
euteration of <25% of exchangeable amides, was observed within
ore regions of the kinase corresponding to helix E and strand 6
ithin the C-terminal lobe, the latter which contains the catalytic
ase within the active site. Slow exchange was also observed in the
ig. 4. HX time courses for peptides showing protection of ERK1 upon nucleotide binding
f AMP–PNP binding to ERK1. HX data on apoenzyme were indicated by closed symbols,
nd 2P-ERK1 showed signiﬁcant protection of HX upon binding AMP–PNP, suggesting intss Spectrometry 302 (2011) 101–109
loop between helix C and 4 as well as in strand 5, which con-
tain residues that create a hydrophobic core within the N-terminal
lobe. In ERK2, these residues form intramolecular connectivities
with distal residues that in turn prevent autophosphorylation and
autoactivation of the enzyme by constraining ﬂexibility at the
activation lip [21]. Fast exchange, leading to >75% deuteration of
exchangeable amides, was observed within loop regions, includ-
ing part of the activation lip and loops connecting the MAP kinase
insert with C-terminal helices G and H. Deuteration exceeding
. (A–H) Peptides from 0P-ERK1 (left panels) and 2P-ERK1 (right panels) show effects
and data collected with AMP–PNP were indicated by open symbols. Both 0P-ERK1
erdomain closure in both inactive and active forms.
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0% of exchangeable amides was also observed within N-terminal
oop regions, the P+1 substrate binding loop, and the MAP kinase
nsert.
The extent of deuteration in ERK1 revealed many similarities
ithpreviousHXmeasurementsof ERK2 [9,11] (Fig. 2AandB). Both
nzymes showed low levels of exchange within the core regions of
he N- and C-terminal domains, including the active site, helices
E and F in the C-terminal domain, and the N-terminal core con-
aining 3–C–4–5. In both enzymes, high levels of exchange
ccurred within loops and peripheral secondary structure includ-
ng the N-terminal strands 1LO-2LO and 1–2, intervening
oop regions between 4–5 and F–G, and the MAPK insert.
nterestingly, some dissimilarities in HX behavior were observed
etween ERK1 and ERK2. Several prominent regions that under-
ent nearly complete in-exchange in ERK2 showed only partial
xchange in ERK1; these included the activation lip and C-terminal
elixL16,which showed <50% exchange in ERK1, but greater than
0% exchange in ERK2. These differences in HX suggested lower
onformational mobility in ERK1 compared to ERK2 within regions
f the molecule linked to catalytic function.
.2. Regulation of HX by ERK1 activation
Time courses comparing 0P-ERK1 to 2P-ERK1 (Supplementary.
ig. S2) revealed signiﬁcant changes in hydrogen exchange behav-
or following activation of ERK1 by dual phosphorylation. Sites
f proteolytic cleavage were nearly identical between the 0P
nd 2P forms, with the exception of the activation lip, where
leavage between residues Glu203 and Tyr204 (numbered as in
ig. 1) was observed only in the unphosphorylated form of ERK1.
n total, eight peptides exhibited altered in-exchange behavior
etween 0P-ERK1 and 2P-ERK1 (Figs. 1 and 3A–H). In 7 of 8 cases,
ig. 5. Summary of results and conceptual model. (A and B) Peptides protected from H
nterdomain interactions leading to domain closure in both 0P- and 2P-ERK1, based on
nterdomain interactions leading to domain closure are enhanced in ERK2 by phosphorylss Spectrometry 302 (2011) 101–109 107
kinase activation led to decreased HX rates; these included pep-
tide 180–187 (LKICDFGL), containing the conserved DFG motif;
peptide 210–216 (YRAPEIM), containing the P+1 substrate bind-
ing loop; peptides 218–232 (NSKGYTKSIDIWSVG) and 236–254
(AEMLSNRPIFPGKHYLDQL), containing F-G; peptides 255–271
(NHILGILGSPSQEDLNC) and 280–306 (YLQSLPSKTKVAWAKLFPKS-
DSKALDL), containing the L14 MAP kinase insert and H;
and peptide 349–365 (AMELDDLPKERLKIELIF), containing the C-
terminal helix L16. These could either reﬂect structural changes
leading to solvent inaccessibility, or else decreased ﬂexibility and
internal motions, following activation lip phosphorylation. Only
one peptide exhibited increased HX upon activation; this region
corresponded to the 7–8 loop (peptide 173–180, LINTTCDL),
which formspart of a dockingmotif binding site (Fig. 3A), andmight
reﬂect increased backbone ﬂexibility within a binding pocket for
high afﬁnity interactions with substrates, MKKs, and other effec-
tors.
The localized regions which showed HX alterations upon kinase
activation were mapped against the backbone structure of ERK1,
and compared to those previously reported for ERK2 (Figs. 2C
and D). ERK1 and ERK2 showed some similarities in the pat-
terns of HX that were correlated with activity. Both enzymes
showed activation-induced changes in HX within the activation
lip, a region which undergoes signiﬁcant conformational remod-
eling in ERK2, which would also be expected to occur in ERK1.
Decreased HX was observed in both enzymes at the C-terminal
L16helix and surrounding regions,which inERK2hasbeen shown
to form an interface for dimerization. Similarly, decreased HX was
observed in both enzymes within the P+1 substrate interaction
loop, as well as helices F and G, which comprise the likely inter-
face for extended substrate binding interactions. ERK2 showed
few structural changes within this region that might account for
X by Mg+2–AMP–PNP binding are shown in color. (C) Model of results, showing
HX protection in the C-terminal domain. (D) Model indicating that in solution,
ation and activation.
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he observed changes in HX, suggesting that reduced hydrogen
xchange rates reﬂected decreased conformational mobility fol-
owing kinase activation. Decreased HX had also been observed in
his region following activation of p38MAP kinase [15], suggest-
ng that decreased ﬂexibility in the substrate binding interface is a
eature common to several MAP kinases.
ERK1 and ERK2 also showed key differences in their pat-
erns of HX regulated by activation. For example, ERK1 showed
o increased HX in the MAP kinase insert, which had previ-
usly been observed in ERK2 and ascribed to disrupted hydrogen
onding with activation lip residues upon kinase activation [9].
ikewise, ERK1 did not recapitulate the increased HX observed
n the glycine-rich loop upon activation of ERK2, a region impli-
ated in nucleotide binding. Importantly, differences were noted
etween the two enzymes in the hinge region localized between
he N- and C-terminal domains, which in cAMP-dependent pro-
ein kinase corresponds to the pivot point for rigid body rotation
nd interdomain closure needed for formation of the catalytic
ite. In ERK2, this region of the hinge (METDL, Supplementary.
ig. S3) showed signiﬁcant enhancement of HX upon activa-
ion, which correlated with altered internal motions, allowing
he kinase to switch from an open to closed solution conforma-
ion [9–11]. In contrast, peptide 125–141 (METDLYKLLKSQQLSND),
eptide 125–145 (METDLYKLLKSQQLSNDHICY), and the overlap-
ing peptide 130–145 (YKLLKSQQLSNDHICY) exhibited no change
n HX behavior between active and inactive states in ERK1, from
hich we conclude that no change in HX occurs within the
orresponding METDL hinge sequence in ERK1 (Fig. 3I and J,
upplementary Fig. S3). This suggested that hinge ﬂexibility is
ot regulated by activation of ERK1 as it is in ERK2, and that the
wo enzymes differ with respect to the regulation of interdomain
losure.
.3. Domain closure in ERK1 can be monitored by HX-MS
The results above suggested that unlike ERK2, the hinge ﬂex-
bility of ERK1 might not be controlled by activity state, and
hus might allow interdomain closure in both inactive and active
orms. In order to test this hypothesis, we conducted an HX-MS
xperiment which measured the steric protection from HX upon
MP–PNP binding to ERK1. Prior studies with ERK2 have shown
hat AMP–PNP protects N-terminal and hinge regions in the inac-
ive and the active kinase, as expected from the known interactions
etween kinases and ATP, and that active ERK2 shows additional
rotection of the conserved DFG motif in the C-terminal domain.
hus, steric protection of the DFG motif reﬂects interdomain clo-
ure between N- and C-terminal lobes in solution. If our hypothesis
ere correct, we would expect to see protection of the DFG motif
omparable in both forms of ERK1.
We measured HX time courses in the presence or absence
f 1mM Mg2+–AMP–PNP, comparing inactive vs active ERK1
Supplementary Fig. S4). Only 20 of the 54 peptides were observed
n these experiments between each of the four conditions, which
evertheless included most of the ERK1 sequence. Of these, four
eptides showed signiﬁcant reduction in HX rates upon AMP–PNP
inding (Fig. 4A–D). Three of these corresponded to regions which
re known to form contacts with nucleotide within the N-terminal
omain. These included peptide 46–69 (QYIGEGAYGMVSSA), con-
aining the glycine loop which forms hydrogen bond interactions
ith  and -phosphate groups of ATP and forms a ﬂexible gate
or nucleotide binding; peptide 60–88 (YDHVRKTRVAIKKISPFEHQ-
YCQRTLRE), containing conserved Lys and Glu residues in strand
3 and helix C, respectively, which form ion-pair interactions
ith ATP  and -phosphate groups; and peptide 115–124 (MRD-
YIVQDL), containing residues in strand 5 which form hydrogen
onding interactions with nucleotide (Fig. 4A–C). The fourth pep-ss Spectrometry 302 (2011) 101–109
tide, peptide 181–187 (KICDFGL), contains the conserved DFG
motif (Fig. 4D). Here, we observed comparable protection upon
AMP–PNP binding to both inactive and active kinase forms. This
was in contrast to the corresponding DFG region in ERK2, where
previous measurements revealed 10-fold greater nucleotide pro-
tection from HX in the active kinase compared to the inactive form
(Supplementary Fig. S5) [11]. Our measurements of ERK1 indicate
that that nucleotide interacts productively with both the N-and C-
terminal domains in 0P- and 2P-ERK1, and more productively with
the C-terminal domain in 0P-ERK1 than 0P-ERK2. Taken together,
the ﬁndings suggest that both inactive and active forms of ERK1 are
able to adopt interdomain interactions leading to a closed confor-
mation in solution.
4. Discussion
This study reveals novel insight into the manner in which inter-
nalmotions inERK1are regulatedbyenzymeactivation, as revealed
by HX-MS. We demonstrate that ERK1 and ERK2, which are 90%
identical inprimary sequence, showdifferences inHXbehavior that
suggest differences in conformational mobility between closely
related kinases.
InterpretationofHX results canbegreatly aidedby the availabil-
ity of information on atomic structure. Numerous X-ray structures
of ERK2 have been solved in varying forms, including unphos-
phorylated, diphosphorylated, peptide-bound, inhibitor-bound, or
harboringmutationswithin the phosphorylation lip and active site.
In contrast, only one X-ray structure of ERK1 has been published
to date, representing a form which is mono-phosphorylated at its
regulatory Tyr residue (1P-ERK1, Ref. [5]), and whose activity is
approximately 10% of the fully active, diphosphorylated enzyme
[17]. The tertiary structure of ERK1 shows a consensus kinase core
structure containing two insertions unique to MAP kinases (LO,
L14). The backbone conformation is very similar to the struc-
ture of ERK2 [6–8], consistent with the extensive sequence identity
between these enzymes. In its conﬁguration of the activation lip,
the 1P-ERK1 structure appearsmost consistentwithwhatwould be
expected for an inactive conformation of the enzyme, resembling
the inactive, unphosphorylated form of ERK2 (0P-ERK2) more than
the active diphosphorylated form (2P-ERK2).
While the overall extent of HX was generally similar between
0P-ERK1 and 0P-ERK2 and consistent with the conserved tertiary
structures, certain dissimilarities were observed. For example, the
extent of HX was lower in ERK1 than ERK2 within the 1LO–2LO
and 1 strands of the N-terminal lobe, and higher in regions sur-
rounding the MAP kinase insertion. Both of these regions showed
signiﬁcant differences in primary sequence as well as structure
(Supplementary Fig. S6 sequence alignment). Likewise, HX was
lower in ERK1 within the 7–8 loop and the C-terminal L16
helix, suggesting lower ﬂexibility. Both regions showed similar
sequences, but higher structural order in ERK1 than ERK2, reﬂected
by closer beta-sheet hydrogenbonding distances in the7–8 loop
of ERK1, as well as an additional helical turn proximal to L16
in ERK1 which was absent in ERK2. Lower HX was also observed
around the activation lip of ERK1, compared to ERK2. Although pri-
mary sequences and conformations were similar between these
regions of ERK1andERK2, residues immediately adjacent to pTyr as
well as within helix C in ERK1 were distorted relative to 0P-ERK2
in a manner suggesting greater similarity to corresponding regions
in 2P-ERK2, which might account for the partial activity of 1P-
ERK1. Thus, for the most part, differences in extent of HX between
ERK1 and ERK2 could be attributed to variations in sequence and/or
structure.
Intriguing differences were observed between ERK1 and ERK2,
when we assessed the effects of phosphorylation and activation
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n conformational mobility. Our previous studies on ERK2 showed
hatenzymeactivation led to signiﬁcant changes inHXwithin local-
zed regions of the protein. These could be attributed to changes
n protein ﬂexibility and internal motions, especially when HX
hanges occurred in a manner inconsistent with structural dif-
erences between 0P-ERK2 and 2P-ERK2. In particular, regions of
RK2 that showed regulated HX ascribed to changes in ﬂexibil-
ty were those implicated in substrate binding or catalysis, which
ould conceivably contribute to enzyme activation. This was fur-
her examined in the hinge region,where increased ﬂexibility upon
inase activation correlated with release of constraints to interdo-
ain closure. In the case of ERK1, the limitedX-ray informationwas
nsufﬁcient to draw dependable conclusions about how well the
hanges inHXcouldbeexplainedbychanges in structurevs internal
otions. Nevertheless, to the extent that ERK1 behaves similarly
o ERK2, whose conformational changes were largely restricted to
he activation lip and active site, our HX measurements on ERK1
ould conceivably reﬂect effects of activation on protein dynamics.
s in ERK2, the regions showing regulated HX in ERK1 are asso-
iated with kinase function. Increased HX in ERK1 upon activation
ay reﬂect increased mobility of the7–8 loop which is involved
n substrate docking motif recognition. Likewise, reduced mobility
pon activationmight also occur in theDFGmotifwhich is involved
n ATP binding, in the C-terminal helix L16, which is involved in
inase dimerization, and in the P+1 loop and helicesF–G,which
orm the interface for substrate binding and recognition.
Notably, differences were observed between the two enzymes
n thehinge region,which inERK2showed increasedbackboneﬂex-
bility upon activation, but in ERK1 showed little change between
ctive and inactive states (Supplementary Fig. S3). Further evi-
ence showing that AMP–PNP interacts productively with N- and
-terminal domains inboth0P-ERK1and2P-ERK1suggests amodel
n which both the active and inactive states of ERK1 allow inter-
omain closure and formation of a closed active site (Fig. 5). This
ehavior differs substantively from ERK2, where constraints to
omain closure consistent with an open solution conformation
ere observed in the inactive, unphosphorylated form, and were
eleased upon activation by diphosphorylation, enabling the for-
ation of a closed solution conformation that would be needed for
atalysis. We conclude that ERK1 and ERK2, while closely related
n sequence and structure, nevertheless differ signiﬁcantly in their
onstraints to kinase activation, and themechanismsbywhich they
vercome these barriers through activation-induced regulation of
onformational mobility.
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